These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
477 related items for PubMed ID: 19114543
21. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions. Koehler SM, Buyuk F, Celebi O, Demiraslan H, Doganay M, Sahin M, Moehring J, Ndumnego OC, Otlu S, van Heerden H, Beyer W. BMC Vet Res; 2017 Jul 12; 13(1):220. PubMed ID: 28701192 [Abstract] [Full Text] [Related]
22. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy. Baillie LW, Rodriguez AL, Moore S, Atkins HS, Feng C, Nataro JP, Pasetti MF. Vaccine; 2008 Nov 11; 26(48):6083-91. PubMed ID: 18805452 [Abstract] [Full Text] [Related]
23. Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine. Zeng M, Xu Q, Pichichero ME. Vaccine; 2007 May 04; 25(18):3588-94. PubMed ID: 17293013 [Abstract] [Full Text] [Related]
24. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection. Reed MD, Wilder JA, Mega WM, Hutt JA, Kuehl PJ, Valderas MW, Chew LL, Liang BC, Squires CH. PLoS One; 2015 May 04; 10(7):e0130952. PubMed ID: 26207820 [Abstract] [Full Text] [Related]
33. Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization. Kobiler D, Gozes Y, Rosenberg H, Marcus D, Reuveny S, Altboum Z. Infect Immun; 2002 Feb 08; 70(2):544-60. PubMed ID: 11796581 [Abstract] [Full Text] [Related]
38. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax. Williamson ED, Hodgson I, Walker NJ, Topping AW, Duchars MG, Mott JM, Estep J, Lebutt C, Flick-Smith HC, Jones HE, Li H, Quinn CP. Infect Immun; 2005 Sep 08; 73(9):5978-87. PubMed ID: 16113318 [Abstract] [Full Text] [Related]
39. Progress and novel strategies in vaccine development and treatment of anthrax. Chitlaru T, Altboum Z, Reuveny S, Shafferman A. Immunol Rev; 2011 Jan 08; 239(1):221-36. PubMed ID: 21198675 [Abstract] [Full Text] [Related]
40. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax. Glinert I, Bar-David E, Sittner A, Weiss S, Schlomovitz J, Ben-Shmuel A, Mechaly A, Altboum Z, Kobiler D, Levy H. Antimicrob Agents Chemother; 2016 Aug 08; 60(8):4878-85. PubMed ID: 27270276 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]